S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
NASDAQ:MRTX

Mirati Therapeutics - MRTX SEC Filings & 10K Form

$53.09
+2.03 (+3.98%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$50.73
$53.60
50-Day Range
$39.81
$98.62
52-Week Range
$32.96
$124.81
Volume
933,779 shs
Average Volume
1.26 million shs
Market Capitalization
$3.06 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$81.47

Recent Mirati Therapeutics SEC Filings

DateFilerForm TypeView
01/24/2023
3:17 PM
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:17 PM
Hasnain Faheem (Reporting)
Hasnain Faheem (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:18 PM
Cherrington Julie M (Reporting)
Mirati Therapeutics (Issuer)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:19 PM
Johnson Craig A (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:20 PM
BAUM CHARLES M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:20 PM
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:20 PM
Davis Aaron I. (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:00 PM
Martinez Maria E (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:00 PM
FUCHS HENRY J (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:00 PM
Mirati Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:00 PM
CARTER BRUCE L A (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:00 PM
Hickey Benjamin (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:00 PM
Meek David D. (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:00 PM
Christensen Jamie (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2023
3:03 PM
Mirati Therapeutics (Issuer)
Sharp Shalini (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2023
8:20 AM
Cherrington Julie M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2023
8:45 AM
Hickey Benjamin (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2023
8:45 AM
Christensen Jamie (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2023
8:45 AM
Meek David D. (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2023
4:00 PM
Hickey Benjamin (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2023
12:06 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2023
4:13 PM
Christensen Jamie (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2023
4:13 PM
BAUM CHARLES M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2022
8:20 PM
Meek David D. (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2022
8:20 PM
Hickey Benjamin (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2022
8:21 PM
BAUM CHARLES M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2022
4:00 PM
Christensen Jamie (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2022
7:01 AM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2022
6:01 PM
BAUM CHARLES M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2022
5:00 PM
Mirati Therapeutics (Issuer)
Sandler Alan B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2022
5:00 PM
Mirati Therapeutics (Issuer)
Sandler Alan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2022
3:32 PM
Mirati Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2022
3:23 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2022
4:35 PM
Christensen Jamie (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2022
5:08 AM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2022
3:15 PM
CARTER BRUCE L A (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2022
4:17 PM
Mirati Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/14/2022
3:35 PM
Christensen Jamie (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2022
7:06 AM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2022
7:07 AM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2022
4:56 PM
Mirati Therapeutics (Issuer)
Stelzer Laurie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2022
4:06 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2022
3:13 PM
Mirati Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/12/2022
4:07 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2022
3:10 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2021
7:10 AM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2021
3:34 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2021
7:41 AM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/25/2021
5:04 PM
Christensen Jamie (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
3:21 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
3:37 PM
Mirati Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/06/2021
7:06 PM
CARTER BRUCE L A (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2021
4:41 PM
Mirati Therapeutics (Issuer)
Sharp Shalini (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/30/2021
4:41 PM
Mirati Therapeutics (Issuer)
Sharp Shalini (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2021
3:42 PM
Hickey Benjamin (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2021
8:30 PM
Braslyn Ltd. (Reporting)
LEWIS JOSEPH (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
8:48 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
Dissanayake Shehan Bharatha (Reporting)
Fuglesang Christopher (Reporting)
LEWIS JOSEPH (Reporting)
LIEBERBURG IVAN M (Reporting)
Mirati Therapeutics (Issuer)
MVA Investors, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:25 PM
Cherrington Julie M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:31 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2021
4:08 PM
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:08 PM
CARTER BRUCE L A (Reporting)
CARTER BRUCE L A (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:09 PM
Faga Daniel (Reporting)
Mirati Therapeutics (Issuer)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
8:47 PM
Martinez Maria E (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2021
4:45 PM
BAUM CHARLES M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
3:31 PM
Johnson Craig A (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:15 PM
Cherrington Julie M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:15 PM
Johnson Craig A (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:16 PM
GREY MICHAEL G (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:16 PM
FUCHS HENRY J (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:17 PM
Martinez Maria E (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:17 PM
CARTER BRUCE L A (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:17 PM
BAUM CHARLES M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:18 PM
Christensen Jamie (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:18 PM
Hickey Benjamin (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:18 PM
Mirati Therapeutics (Issuer)
REED VICKIE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:14 PM
Faga Daniel (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:14 PM
Hasnain Faheem (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2021
5:15 PM
Davis Aaron I. (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
6:31 AM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
6:57 PM
Mirati Therapeutics (Issuer)
REED VICKIE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
6:46 PM
Hickey Benjamin (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
6:14 PM
BAUM CHARLES M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
6:15 PM
Faga Daniel (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
6:15 PM
Christensen Jamie (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2020
5:39 PM
BAUM CHARLES M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
5:28 PM
BAUM CHARLES M (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
4:36 PM
GREY MICHAEL G (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
4:37 PM
CARTER BRUCE L A (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2020
4:37 PM
FUCHS HENRY J (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
6:35 PM
Mirati Therapeutics (Issuer)
REED VICKIE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
4:59 PM
Christensen Jamie (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2020
3:47 PM
Mirati Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2020
3:36 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2020
8:53 PM
Braslyn Ltd. (Reporting)
LEWIS JOSEPH (Reporting)
Mirati Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2020
8:54 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
Dissanayake Shehan Bharatha (Reporting)
Fuglesang Christopher (Reporting)
LEWIS JOSEPH (Reporting)
LIEBERBURG IVAN M (Reporting)
Mirati Therapeutics (Issuer)
MVA Investors, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2020
8:28 PM
Lockend Five, LLC (Reporting)
Mirati Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/28/2020
3:38 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2020
3:53 PM
Mirati Therapeutics (Filer)
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2020
3:53 PM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2020
7:00 AM
Mirati Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page (NASDAQ:MRTX) was last updated on 1/29/2023 by MarketBeat.com Staff